Robert Davis death hospital patient Robert Davis

New COVID-19 Pill Reduces Risk of Death & Hospitalization by 50%, According to Study

Reading now: 134
justjared.com

An experimental coronavirus treatment pill is making headlines on Friday (October 1). The oral drug, called molnupiravir, is being developed by Merck & Co Inc.

and Ridgeback Biotherapeutics LP, and reduced hospitalization and death by around 50% according to clinical trial results, via Reuters. Click inside to read more… The companies plan to seek U.S.

emergency use authorization for the pill as soon as possible, as well as worldwide. If it is authorized, it will be the first oral antiviral medication for COVID-19. “This is going to change the dialogue around how to manage COVID-19,” said Merck’s Robert Davis to Reuters.

Read more on justjared.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA